Title : The 29.5 kb APOBEC3B Deletion Polymorphism Is Not Associated with Clinical Outcome of Breast Cancer.

Pub. Date : 2016

PMID : 27552096






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The predictive value of the APOBEC3B deletion was assessed among 329 ER-positive breast cancer patients who received tamoxifen as the first-line therapy for recurrent disease and 226 breast cancer patients who received first-line chemotherapy for recurrent disease. Tamoxifen apolipoprotein B mRNA editing enzyme catalytic subunit 3B Homo sapiens